Gene: CSF1
Official Full Name: colony stimulating factor 1provided by HGNC
Gene Summary: The protein encoded by this gene is a cytokine that controls the production, differentiation, and function of macrophages. The active form of the protein is found extracellularly as a disulfide-linked homodimer, and is thought to be produced by proteolytic cleavage of membrane-bound precursors. The encoded protein may be involved in development of the placenta. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10881 | CSF1 Knockout cell line (HeLa) | Human | CSF1 | 1:3~1:6 | Negative | Online Inquiry |
KO10882 | CSF1 Knockout cell line (HCT 116) | Human | CSF1 | 1:2~1:4 | Negative | Online Inquiry |
KO10883 | CSF1 Knockout cell line (HEK293) | Human | CSF1 | 1:3~1:6 | Negative | Online Inquiry |
KO10884 | CSF1 Knockout cell line (A549) | Human | CSF1 | 1:3~1:4 | Negative | Online Inquiry |
CSF1 Gene Knockout Cell Lines are specialized cell models engineered to disrupt the expression of the colony-stimulating factor 1 (CSF1) gene, which plays a critical role in the regulation of monocyte and macrophage differentiation and function. These cell lines are invaluable tools for researchers investigating the immune response, specifically in the context of macrophage biology, tissue homeostasis, and various disease models.
The primary function of CSF1 is to stimulate the proliferation and differentiation of monocytes into macrophages, which are essential for immune responses, tissue repair, and homeostasis. By utilizing these knockout cell lines, researchers can study the direct impact of the absence of CSF1 on macrophage development and behavior. The mechanism of action involves the CRISPR/Cas9 gene-editing technology, which ensures precise editing of the CSF1 gene, enabling in-depth analyses of phenotypic and functional outcomes associated with macrophage signaling pathways.
In scientific research and clinical settings, CSF1 Gene Knockout Cell Lines serve as critical models for studying inflammatory diseases, cancer microenvironments, and immune disorders. Understanding the role of CSF1 in macrophage function can lead to the development of novel therapeutics targeting macrophage-driven conditions, providing important insights into alternative treatment strategies.
The advantages of our CSF1 Gene Knockout Cell Lines are their high specificity and reproducibility, alongside optimal viability compared to existing models. Unlike alternative models, our product is extensively validated to ensure consistent results, making it easier for researchers to generate reliable data with minimal variability. This is particularly critical when exploring complex immunological interactions and therapeutic interventions.
By providing these tools, we empower researchers and clinicians to advance the understanding of macrophage biology and its implications for human health. Our commitment to quality and excellence in biological products is demonstrated through our rigorous development processes and a strong foundation in biotechnological innovation, ensuring that our offerings meet the highest scientific standards.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.